IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.8746
-0.0264 (-2.93%)
At close: Oct 29, 2025, 4:00 PM EDT
0.8512
-0.0234 (-2.68%)
Pre-market: Oct 30, 2025, 7:24 AM EDT
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $57.62 million as of October 30, 2025. Its market cap has decreased by -24.60% in one year.
Market Cap
57.62M
Enterprise Value
37.84M
1-Year Change
-24.60%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $57.62M, a decrease of -84.40%. That is a compound annual growth rate of -37.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 57.62M | -4.93% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
| Nov 5, 2021 | 369.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.94B |
| Johnson & Johnson | 450.55B |
| AbbVie | 403.22B |
| UnitedHealth Group | 336.43B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.49B |